7 results
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
The BLUE-protocol ... combines signs, associates ... #BLUE #protocol ... #Algorithm #Dyspnea ... #CriticalCare #POCUS
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
The BLUE-protocol ... combines signs, associates ... The A-profile associates ... #protocol #Algorithm ... #CriticalCare #POCUS
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
The BLUE-protocol ... the ICU The BLUE-protocol ... combines signs, associates ... The A-profile associates ... dyspnea-criticalcare-pulmonary-algorithm-pocus
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
of interstitial lung ... disease (ILD)-associated ... #lungdisease #ILD ... management #treatment #algorithm
ANTI-MDA5 DERMATOMYOSITIS

Cutaneous manifestations:
• Periorbital heliotrope (blue-purple) rash with edema
• Erythematous rash on the face, or the
Periorbital heliotrope (blue-purple ... severity of the disease ... and ILD • Liver ... increases and ILD ... anti-NXP2 Abs Lung
Algorithm for Diagnosis of Diffuse Cystic Lung Disease (DCLD)
Round, smooth cysts with normal lung parenchyma in
Algorithm for Diagnosis ... Disease (DCLD) ... May have associated ... presentations - ILD ... #Disease #DCLD
Anti-NXP-2 Dermatomyositis

What?
DM with generalized subcutaneous edema
Pts have more myalgias, more severe weakness, and an increased prevalence
Periorbital heliotrope (blue-purple ... papules: can be associated ... had more severe disease ... Non-small-cell lung ... Dermatomyositis: • ILD